Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Alector, Inc. (ALEC)
USD1.48
+0.09 (+6.12%)
US NASDAQ Healthcare Biotechnology
Address
131 Oyster Point Boulevard 94080
South San Francisco, CA, US
South San Francisco, CA, US
CEO
Arnon Rosenthal
Website
alector.com
IPO
2019-02-07
CIK 1653087 ISIN US0144421072
Description
Alector, Inc. is a clinical-stage biopharmaceutical company dedicated to pioneering new treatments for neurodegenerative disorders. A key program in its pipeline is AL001, a humanized recombinant monoclonal antibody currently undergoing Phase III clinical trials. This investigational therapy targets a range of severe conditions, including frontotemporal dementia, Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS). Additionally, AL101 is progressing through Phase I clinical trials for general neurodegenerative diseases, with a specific focus on Alzheimer's and Parkinson's. Further bolstering its Alzheimer's portfolio, Alector is evaluating AL002 in Phase II studies and AL003 in Phase I studies, both aimed at addressing Alzheimer's disease. In earlier-stage development, the company is also developing AL044, which targets the MS4A4A gene, identified as a risk factor for Alzheimer's disease. Alector has forged key partnerships to advance its mission. It collaborates with Adimab, LLC on antibody research and development. Furthermore, a significant strategic alliance with GlaxoSmithKline plc (GSK) focuses on the joint development and commercialization of monoclonal antibodies, specifically AL001 and AL101, for neurodegenerative conditions. Established in 2013, Alector's headquarters are located in South San Francisco, California.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD1.48
+0.09 (+6.12%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
707.1K
Beta
0.59
Float Shares
75.24M
Free Float %
67.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +5.37% | -15.63% | -11.84% | +13.68% | +61.19% | +38.46% | +80.00% | -70.61% | -87.14% | -88.00% | -88.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (14 ratings, all time)
Buy
Price Targets & DCF
Current price
1.48
Low
2.00
+35.6%
Consensus
2.00
+35.6%
Median
2.00
+35.6%
High
2.00
+35.6%
Ratings Trend (MoM)
38% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 3 | 0 |
| Hold | 3 | -1 |
| Sell | 1 | 0 |
| Strong Sell | 1 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
2.00
+35.6%
|
| Last Quarter | 1 |
2.00
+35.6%
|
| Last Year | 3 |
2.83
+91.9%
|
| All Time | 4 |
3.13
+112.2%
|
Quality scores
Altman Z-Score
-6.10
Distress
Piotroski F-Score
1 / 9
Weak
MOAT Score
1 / 10
No MOAT
Composite Rating
D+
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-79.1% Q1'26: -71.5% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%-13.0% Q1'26: +48.8% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-985.4% Q1'26: -4,773.5% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-678.4% Q1'26: -2,411.0% (vs Q1'25)
-
ROIC Biotechnology: -16.1%— Q1'26: +62.4% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+6.6% Q1'26: +11.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.27× Q1'26: -0.37× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 5 EPS Ana. |
Dec 2027 5 Rev. Ana. 6 EPS Ana. |
Dec 2028 5 Rev. Ana. 4 EPS Ana. |
Dec 2029 2 Rev. Ana. 2 EPS Ana. |
Dec 2030 2 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
27.68M
est: 22.43M (+23.4%)
|
21.22M
est: 21.63M (-1.9%)
|
21.10M
est: 24.15M (-12.6%)
|
207.09M
est: 243.75M (-15.0%)
|
133.62M
est: 150.84M (-11.4%)
|
97.06M
est: 55.28M (+75.6%)
|
100.56M
est: 65.66M (+53.2%)
|
21.05M
est: 16.92M (+24.4%)
|
27.86M
4.80M – 68.81M
+64.7% YoY
|
27.27M
17.71M – 36.81M
-2.1% YoY
|
8.11M
2.21M – 18.11M
-70.3% YoY
|
15.76M
4.29M – 35.21M
+94.4% YoY
|
19.06M
5.19M – 42.58M
+20.9% YoY
|
| EBITDA |
-56.27M
est: -18.43M (-205.3%)
|
-109.47M
est: -17.77M (-516.0%)
|
-187.91M
est: -154.95M (-21.3%)
|
-29.05M
est: -7.66M (-279.1%)
|
-129.36M
est: -123.94M (-4.4%)
|
-142.89M
est: -45.42M (-214.6%)
|
-136.16M
est: -53.95M (-152.4%)
|
-133.10M
est: -13.90M (-857.4%)
|
-22.90M
-56.54M – -3.95M
-64.7% YoY
|
-22.40M
-30.25M – -14.55M
+2.1% YoY
|
-6.66M
-14.88M – -1.81M
+70.3% YoY
|
-12.95M
-28.93M – -3.53M
-94.4% YoY
|
-15.66M
-34.99M – -4.26M
-20.9% YoY
|
| EBIT |
-57.29M
est: -18.75M (-205.5%)
|
-113.25M
est: -18.08M (-526.3%)
|
-195.17M
est: -165.10M (-18.2%)
|
-37.36M
est: -18.90M (-97.7%)
|
-137.83M
est: -126.11M (-9.3%)
|
-151.74M
est: -46.21M (-228.3%)
|
-145.00M
est: -54.90M (-164.1%)
|
-142.76M
est: -14.15M (-909.2%)
|
-23.30M
-57.53M – -4.01M
-64.7% YoY
|
-22.80M
-30.78M – -14.80M
+2.1% YoY
|
-6.78M
-15.15M – -1.85M
+70.3% YoY
|
-13.17M
-29.44M – -3.59M
-94.4% YoY
|
-15.93M
-35.60M – -4.34M
-20.9% YoY
|
| Net Income |
-52.25M
est: -99.00M (+47.2%)
|
-105.39M
est: -158.68M (+33.6%)
|
-190.23M
est: -161.10M (-18.1%)
|
-36.33M
est: -17.70M (-105.2%)
|
-133.31M
est: -143.06M (+6.8%)
|
-130.39M
est: -160.66M (+18.8%)
|
-119.05M
est: -182.73M (+34.9%)
|
-142.93M
est: -145.69M (+1.9%)
|
-96.98M
-127.48M – 38.50M
+33.4% YoY
|
-99.94M
-116.65M – -37.85M
-3.0% YoY
|
-76.05M
-97.64M – -54.47M
+23.9% YoY
|
-67.72M
-176.42M – -3.66M
+11.0% YoY
|
-39.14M
-101.96M – -2.12M
+42.2% YoY
|
| SGA |
11.93M
est: 21.15M (-43.6%)
|
33.94M
est: 20.39M (+66.4%)
|
59.40M
est: 22.77M (+160.9%)
|
55.04M
est: 67.20M (-18.1%)
|
61.03M
est: 142.24M (-57.1%)
|
56.69M
est: 49.36M (+14.8%)
|
59.62M
est: 58.63M (+1.7%)
|
53.99M
est: 15.11M (+257.3%)
|
24.88M
4.29M – 61.44M
+64.7% YoY
|
24.35M
15.81M – 32.87M
-2.1% YoY
|
7.24M
1.97M – 16.18M
-70.3% YoY
|
14.07M
3.83M – 31.44M
+94.4% YoY
|
17.02M
4.63M – 38.02M
+20.9% YoY
|
| EPS |
-0.76
est: -1.03 (+25.9%)
|
-1.62
est: -1.64 (+1.4%)
|
-2.45
est: -2.43 (-0.6%)
|
-0.45
est: 0.10 (-566.2%)
|
-1.62
est: -1.39 (-16.6%)
|
-1.56
est: -1.79 (+12.8%)
|
-1.23
est: -1.77 (+30.7%)
|
-1.39
est: -1.40 (+0.4%)
|
-0.77
-1.24 – 0.37
+44.6% YoY
|
-0.78
-1.13 – -0.37
-1.0% YoY
|
-0.77
-0.95 – -0.53
+0.9% YoY
|
-0.66
-1.71 – -0.04
+15.0% YoY
|
-0.38
-0.99 – -0.02
+42.2% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-01 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-213.28M
OE per share TTM
-2.05
Owner's Yield
-91.84%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
57.3%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
39
Total invested
19.99M
Insider transactions (90d)
0
Beneficial owners (>5%)
35
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Terrance G. McGuire | 12.87M | 18.70% | 15.0K | 12.86M | 15.0K | 12.86M | IN | — | 2020-02-12 | ↗ |
| 2 | Amir Nashat | 12.86M | 18.70% | — | 12.86M | — | 12.86M | IN | — | 2020-02-12 | ↗ |
| 3 | Brian Chee | 12.86M | 18.70% | — | 12.86M | — | 12.86M | IN | — | 2020-02-12 | ↗ |
| 4 | Bryce Youngren | 12.86M | 18.70% | — | 12.86M | — | 12.86M | IN | — | 2020-02-12 | ↗ |
| 5 | David Barrett | 12.86M | 18.70% | — | 12.86M | — | 12.86M | IN | — | 2020-02-12 | ↗ |
| 6 | Jonathan A. Flint | 12.86M | 18.70% | — | 12.86M | — | 12.86M | IN | — | 2020-02-12 | ↗ |
| 7 | Polaris Venture Management Co VI, L.L.C. | 12.86M | 18.70% | 12.86M | — | 12.86M | — | OO | — | 2020-02-12 | ↗ |
| 8 | Peter Kolchinsky | 9.70M | 9.90% | — | 9.70M | — | — | HC, IN | Delaware | 2024-12-06 | ↗ |
| 9 | RA Capital Healthcare Fund, L.P. | 9.70M | 9.90% | — | 9.70M | — | — | PN | Delaware | 2024-12-06 | ↗ |
| 10 | RA Capital Management, L.P. | 9.70M | 9.90% | — | 9.70M | — | — | IA, PN | Delaware | 2024-12-06 | ↗ |
| 11 | Rajeev Shah | 9.70M | 9.90% | — | 9.70M | — | — | HC, IN | Delaware | 2024-12-06 | ↗ |
| 12 | Polaris Venture Partners VI (AIV), L.P. | 9.35M | 13.60% | 9.35M | — | 9.35M | — | PN | — | 2020-02-12 | ↗ |
| 13 | 2 | 6.56M | 8.00% | 2.63M | 3.93M | 2.63M | 3.93M | IN | — | 2022-02-14 | ↗ |
| 14 | Federated Hermes, Inc. | 5.28M | 6.50% | 5.28M | — | 5.28M | — | HC | Citizenship or place of Organization | 2022-02-14 | ↗ |
| 15 | J. Christopher Donahue | 5.28M | 6.50% | — | 5.28M | — | 5.28M | IN | Citizenship or place of Organization | 2022-02-14 | ↗ |
| 16 | Rhodora J. Donahue | 5.28M | 6.50% | — | 5.28M | — | 5.28M | IN | Citizenship or place of Organization | 2022-02-14 | ↗ |
| 17 | Thomas R. Donahue | 5.28M | 6.50% | — | 5.28M | — | 5.28M | IN | Citizenship or place of Organization | 2022-02-14 | ↗ |
| 18 | Voting Shares Irrevocable Trust | 5.28M | 6.50% | 5.28M | — | 5.28M | — | OO | Citizenship or place of Organization | 2022-02-14 | ↗ |
| 19 | (1) BlackRock, Inc. | 5.16M | 6.50% | 4.98M | — | 5.16M | — | HC | Delaware | 2021-02-02 | ↗ |
| 20 | The Vanguard Group - 23-1945930 | 5.00M | 6.31% | — | — | — | 140.8K | IA | Pennsylvania | 2021-02-10 | ↗ |
| 21 | EcoR1 Capital, LLC | 4.99M | 11.00% | — | 4.99M | — | 4.99M | IA, OO | Delaware | 2022-02-14 | ↗ |
| 22 | Oleg Nodelman | 4.99M | 11.00% | — | 4.99M | — | 4.99M | HC, IN | United States | 2022-02-14 | ↗ |
| 23 | Morgan Stanley | 4.61M | 5.50% | 13.00 | — | 13.00 | 4.61M | HC, CO | — | 2024-02-12 | ↗ |
| 24 | EcoR1 Capital Fund Qualified, L.P. | 4.54M | 11.00% | — | 4.54M | — | 4.54M | PN | Delaware | 2022-02-14 | ↗ |
| 25 | MRL Ventures Fund LLC | 3.55M | 5.10% | 3.55M | — | 3.55M | — | OO | Delaware | 2019-02-14 | ↗ |
| 26 | Merck & Co., Inc. | 3.55M | 5.10% | 3.55M | — | 3.55M | — | HC | New Jersey | 2019-02-14 | ↗ |
| 27 | Merck Sharp & Dohme Corp. | 3.55M | 5.10% | 3.55M | — | 3.55M | — | CO | New Jersey | 2019-02-14 | ↗ |
| 28 | OrbiMed Advisors LLC | 2.73M | 3.50% | — | 2.73M | — | 10.00 | IA | Delaware | 2020-07-16 | ↗ |
| 29 | OrbiMed Capital GP IV LLC | 2.73M | 3.50% | — | 2.73M | — | 10.00 | OO | Delaware | 2020-07-16 | ↗ |
| 30 | PVP VI (AIV) Feeder Corp. Holding Partnership, L.P. | 2.30M | 3.30% | 2.30M | — | 2.30M | — | PN | — | 2020-02-12 | ↗ |
| 31 | Deerfield Management Company, L.P. | 1.96M | 2.86% | — | 1.96M | — | — | PN | Delaware | 2019-02-11 | ↗ |
| 32 | Polaris Venture Partners Founders’ Fund VI, L.P. | 709.9K | 1.00% | 709.9K | — | 709.9K | — | PN | — | 2020-02-12 | ↗ |
| 33 | Deerfield Private Design Fund III, L.P. | 527.6K | 0.77% | — | 527.6K | — | — | PN | Delaware | 2019-02-11 | ↗ |
| 34 | Polaris Venture Partners VI, L.P. | 498.5K | 0.70% | 498.5K | — | 498.5K | — | PN | — | 2020-02-12 | ↗ |
| 35 | OrbiMed Capital LLC | 291.5K | 0.43% | — | 291.5K | — | 10.00 | OO | Cayman Islands | 2019-02-20 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
39
-95 vs prev Q
New positions
11
Closed positions
101
Increased
23
Reduced
8
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | — | 900.0K +900.0K (+100.0%) | 1.40B +1.4B (+100.0%) | 0.88% +0.877 pp | 0.41% +0.414 pp | USD1.56 +0.0% | 1 qtrs NEW |
| 2 | NANO CAP NEW MILLENNIUM GROWTH FUND L P | 200.0K +200.0K (+100.0%) | 312.00M +312.0M (+100.0%) | 0.19% +0.195 pp | 0.27% +0.266 pp | USD1.56 +0.0% | 1 qtrs NEW |
| 3 | TCG CROSSOVER MANAGEMENT, LLC | 10.00M +10.0M (+100.0%) | 15.60M +15.6M (+100.0%) | 9.75% +9.747 pp | 0.52% +0.516 pp | USD1.56 +0.0% | 1 qtrs NEW |
| 4 | BLACKROCK, INC. | 7.15M -50.2K (-0.7%) | 11.15M -10.2M (-47.7%) | 6.97% -0.205 pp | 0.00% 0.000 pp | USD4.66 -66.5% | 6 qtrs — |
| 5 | VANGUARD GROUP INC | 6.91M +873.4K (+14.5%) | 10.78M -7.1M (-39.7%) | 6.73% +0.721 pp | 0.00% 0.000 pp | USD12.44 -87.5% | 28 qtrs — |
| 6 | FORESITE CAPITAL MANAGEMENT IV, LLC | 3.89M +3.9M (+100.0%) | 6.06M +6.1M (+100.0%) | 3.79% +3.789 pp | 2.64% +2.640 pp | USD1.56 +0.0% | 1 qtrs NEW |
| 7 | MERCK & CO., INC. | 3.55M +— (+0.0%) | 5.53M -5.0M (-47.3%) | 3.46% -0.077 pp | 2.00% -2.601 pp | USD1.89 -17.5% | 5 qtrs — |
| 8 | ACADIAN ASSET MANAGEMENT LLC | 3.44M +1.1M (+45.1%) | 5.36M -1.7M (-23.6%) | 3.36% +0.991 pp | 0.01% -0.003 pp | USD2.46 -36.6% | 17 qtrs — |
| 9 | 683 CAPITAL MANAGEMENT, LLC | 3.35M +2.4M (+235.0%) | 5.23M +2.3M (+76.6%) | 3.27% +2.269 pp | 0.23% +0.073 pp | USD1.98 -21.2% | 2 qtrs — |
| 10 | BALYASNY ASSET MANAGEMENT L.P. | 3.27M +3.3M (+100.0%) | 5.09M +5.1M (+100.0%) | 3.18% +3.183 pp | 0.01% +0.007 pp | USD1.56 +0.0% | 1 qtrs NEW |
| 11 | D. E. SHAW & CO., INC. | 2.37M +1.4M (+141.8%) | 3.69M +794.2K (+27.4%) | 2.31% +1.331 pp | 0.00% +0.000 pp | USD2.23 -30.0% | 11 qtrs — |
| 12 | FMR LLC | 2.23M -13.0M (-85.3%) | 3.48M -41.5M (-92.3%) | 2.17% -12.951 pp | 0.00% -0.002 pp | USD10.35 -84.9% | 28 qtrs — |
| 13 | JACOBS LEVY EQUITY MANAGEMENT, INC | 2.17M +942.2K (+76.5%) | 3.39M -253.5K (-7.0%) | 2.12% +0.892 pp | 0.01% -0.001 pp | USD3.72 -58.1% | 14 qtrs — |
| 14 | IKARIAN CAPITAL, LLC | 2.08M +1.3M (+174.0%) | 3.25M +999.3K (+44.4%) | 2.03% +1.273 pp | 0.25% +0.027 pp | USD1.68 -7.1% | 5 qtrs — |
| 15 | GEODE CAPITAL MANAGEMENT, LLC | 2.08M +214.0K (+11.5%) | 3.24M -2.3M (-41.2%) | 2.02% +0.168 pp | 0.00% 0.000 pp | USD11.66 -86.6% | 28 qtrs — |
| 16 | KYNAM CAPITAL MANAGEMENT, LP | 2.00M +2.0M (+100.0%) | 3.12M +3.1M (+100.0%) | 1.95% +1.949 pp | 0.20% +0.199 pp | USD1.56 +0.0% | 1 qtrs NEW |
| 17 | STATE STREET CORP | 1.81M +79.6K (+4.6%) | 2.83M -2.3M (-44.9%) | 1.77% +0.040 pp | 0.00% 0.000 pp | USD11.68 -86.6% | 28 qtrs — |
| 18 | RENAISSANCE TECHNOLOGIES LLC | 1.54M +594.5K (+62.6%) | 2.41M -401.4K (-14.3%) | 1.50% +0.559 pp | 0.00% +0.000 pp | USD4.45 -64.9% | 17 qtrs — |
| 19 | MEDICI CAPITAL LLC | 1.50M +1.0M (+211.3%) | 2.34M +914.2K (+64.1%) | 1.46% +0.982 pp | 1.88% +0.849 pp | USD2.55 -38.8% | 13 qtrs — |
| 20 | MILLENNIUM MANAGEMENT LLC | 1.33M +177.9K (+15.4%) | 2.08M -1.3M (-39.2%) | 1.30% +0.148 pp | 0.00% -0.001 pp | USD2.46 -36.6% | 28 qtrs — |
| 21 | EUCLIDEAN CAPITAL LLC | 1.31M +— (+0.0%) | 2.04M -1.8M (-47.3%) | 1.27% -0.028 pp | 0.55% -1.074 pp | USD12.97 -88.0% | 21 qtrs — |
| 22 | MARSHALL WACE, LLP | 1.17M +1.0M (+669.5%) | 1.82M +1.4M (+305.5%) | 1.14% +0.986 pp | 0.00% +0.001 pp | USD1.74 -10.3% | 8 qtrs — |
| 23 | ADAR1 CAPITAL MANAGEMENT, LLC | 1.11M +1.1M (+100.0%) | 1.73M +1.7M (+100.0%) | 1.08% +1.080 pp | 0.13% +0.127 pp | USD1.56 +0.0% | 8 qtrs — |
| 24 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1.06M +— (+0.0%) | 1.65M -1.5M (-47.3%) | 1.03% -0.023 pp | 0.02% -0.027 pp | USD17.65 -91.2% | 28 qtrs — |
| 25 | TWO SIGMA INVESTMENTS, LP | 1.04M +732.5K (+238.5%) | 1.62M +712.6K (+78.4%) | 1.01% +0.707 pp | 0.00% +0.001 pp | USD2.77 -43.7% | 18 qtrs — |
| 26 | DEUTSCHE BANK AG\ | 1.04M -33.1K (-3.1%) | 1.61M -1.5M (-48.9%) | 1.01% -0.055 pp | 0.00% -0.001 pp | USD7.26 -78.5% | 28 qtrs — |
| 27 | EVERSEPT PARTNERS, LP | 1.01M -482.6K (-32.4%) | 1.57M -2.8M (-64.4%) | 0.98% -0.503 pp | 0.08% -0.225 pp | USD1.84 -15.2% | 8 qtrs — |
| 28 | JANE STREET GROUP, LLC | 993.9K +643.7K (+183.8%) | 1.55M +513.8K (+49.6%) | 0.97% +0.620 pp | 0.00% +0.000 pp | USD2.07 -24.6% | 11 qtrs — |
| 29 | DAFNA CAPITAL MANAGEMENT LLC | 908.4K +110.0K (+13.8%) | 1.42M -946.1K (-40.0%) | 0.89% +0.090 pp | 0.33% -0.255 pp | USD9.70 -83.9% | 28 qtrs — |
| 30 | PANAGORA ASSET MANAGEMENT INC | 850.3K +109.0K (+14.7%) | 1.33M -867.8K (-39.5%) | 0.83% +0.090 pp | 0.00% -0.004 pp | USD4.19 -62.8% | 17 qtrs — |
| 31 | VESTAL POINT CAPITAL, LP | 755.0K -225.0K (-23.0%) | 1.18M -1.7M (-59.4%) | 0.74% -0.241 pp | 0.04% -0.091 pp | USD1.32 +18.2% | 4 qtrs — |
| 32 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 665.5K -24.0K (-3.5%) | 1.04M -1.0M (-49.1%) | 0.65% -0.038 pp | 0.00% 0.000 pp | USD11.66 -86.6% | 28 qtrs — |
| 33 | TWO SIGMA ADVISERS, LP | 651.8K +134.4K (+26.0%) | 1.02M -514.7K (-33.6%) | 0.64% +0.120 pp | 0.00% -0.001 pp | USD7.16 -78.2% | 23 qtrs — |
| 34 | MACKENZIE FINANCIAL CORP | 660.2K +376.5K (+132.7%) | 1.00M +161.7K (+19.3%) | 0.64% +0.361 pp | 0.00% +0.000 pp | USD1.51 +3.3% | 3 qtrs — |
| 35 | AQR CAPITAL MANAGEMENT LLC | 599.6K +161.5K (+36.9%) | 935.3K -361.4K (-27.9%) | 0.58% +0.148 pp | 0.00% 0.000 pp | USD3.07 -49.2% | 18 qtrs — |
| 36 | XTX TOPCO LTD | 592.8K +494.3K (+501.8%) | 924.8K +633.2K (+217.2%) | 0.58% +0.480 pp | 0.02% +0.009 pp | USD1.75 -10.9% | 11 qtrs — |
| 37 | NORTHERN TRUST CORP | 587.7K -46.1K (-7.3%) | 916.7K -959.0K (-51.1%) | 0.57% -0.059 pp | 0.00% 0.000 pp | USD15.02 -89.6% | 28 qtrs — |
| 38 | BOOTHBAY FUND MANAGEMENT, LLC | 559.7K +35.6K (+6.8%) | 873.2K -678.1K (-43.7%) | 0.55% +0.023 pp | 0.01% -0.010 pp | USD1.83 -14.8% | 5 qtrs — |
| 39 | GOLDMAN SACHS GROUP INC | 438.0K -172.0K (-28.2%) | 683.2K -1.1M (-62.2%) | 0.43% -0.181 pp | 0.00% 0.000 pp | USD6.10 -74.4% | 28 qtrs — |
| 40 | DEKABANK DEUTSCHE GIROZENTRALE | 100.0K +— (+0.0%) | 661.0K +358.0K (+118.2%) | 0.10% -0.002 pp | 0.00% +0.001 pp | USD7.29 -78.6% | 22 qtrs — |
| 41 | BARCLAYS PLC | 398.7K +221.9K (+125.5%) | 622.0K -201.9K (-24.5%) | 0.39% +0.212 pp | 0.00% 0.000 pp | USD3.18 -50.9% | 28 qtrs — |
| 42 | AMERIPRISE FINANCIAL INC | 354.3K +80.3K (+29.3%) | 552.7K -258.5K (-31.9%) | 0.35% +0.072 pp | 0.00% 0.000 pp | USD2.79 -44.1% | 24 qtrs — |
| 43 | MORGAN STANLEY | 319.1K -115.1K (-26.5%) | 497.8K -787.4K (-61.3%) | 0.31% -0.122 pp | 0.00% +0.000 pp | USD4.52 -65.5% | 28 qtrs — |
| 44 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 291.2K -17.5K (-5.7%) | 454.2K -459.4K (-50.3%) | 0.28% -0.024 pp | 0.00% 0.000 pp | USD2.85 -45.3% | 26 qtrs — |
| 45 | INVESCO LTD. | 279.5K +87.2K (+45.3%) | 436.0K -133.3K (-23.4%) | 0.27% +0.081 pp | 0.00% +0.000 pp | USD2.64 -40.9% | 20 qtrs — |
| 46 | GSA CAPITAL PARTNERS LLP | 225.6K +225.6K (+100.0%) | 352.0K +352.0K (+100.0%) | 0.22% +0.220 pp | 0.03% +0.030 pp | USD1.56 +0.0% | 3 qtrs — |
| 47 | BANK OF NEW YORK MELLON CORP | 217.9K -6.6K (-2.9%) | 339.9K -324.6K (-48.9%) | 0.21% -0.011 pp | 0.00% 0.000 pp | USD13.93 -88.8% | 28 qtrs — |
| 48 | DIMENSIONAL FUND ADVISORS LP | 199.1K -96.7K (-32.7%) | 310.5K -565.5K (-64.6%) | 0.19% -0.101 pp | 0.00% 0.000 pp | USD5.94 -73.7% | 23 qtrs — |
| 49 | CANADA PENSION PLAN INVESTMENT BOARD | 172.3K +172.3K (+100.0%) | 268.8K +268.8K (+100.0%) | 0.17% +0.168 pp | 0.00% +0.000 pp | USD1.56 +0.0% | 1 qtrs NEW |
| 50 | PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | 136.0K +67.8K (+99.4%) | 212.2K +10.3K (+5.1%) | 0.13% +0.065 pp | 0.00% +0.000 pp | USD2.17 -28.1% | 3 qtrs — |
| 51 | BANK OF AMERICA CORP /DE/ | 134.5K -111.8K (-45.4%) | 209.8K -519.2K (-71.2%) | 0.13% -0.114 pp | 0.00% +0.000 pp | USD11.66 -86.6% | 28 qtrs — |
| 52 | UTAH RETIREMENT SYSTEMS | 133.7K +61.7K (+85.7%) | 208.6K -4.5K (-2.1%) | 0.13% +0.059 pp | 0.00% 0.000 pp | USD4.65 -66.5% | 17 qtrs — |
| 53 | NUVEEN, LLC | 133.2K +— (+0.0%) | 207.9K -186.5K (-47.3%) | 0.13% -0.003 pp | 0.00% +0.000 pp | USD1.25 +24.8% | 4 qtrs — |
| 54 | UBS GROUP AG | 119.4K -111.1K (-48.2%) | 186.3K -496.0K (-72.7%) | 0.12% -0.113 pp | 0.00% 0.000 pp | USD3.94 -60.4% | 28 qtrs — |
| 55 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 115.0K +— (+0.0%) | 179.4K -161.0K (-47.3%) | 0.11% -0.003 pp | 0.00% -0.004 pp | USD1.40 +11.4% | 3 qtrs — |
| 56 | STRS OHIO | 110.4K +— (+0.0%) | 172.2K -154.6K (-47.3%) | 0.11% -0.002 pp | 0.00% -0.001 pp | USD12.57 -87.6% | 18 qtrs — |
| 57 | GRAHAM CAPITAL MANAGEMENT, L.P. | 104.9K +83.6K (+394.2%) | 163.6K +100.8K (+160.5%) | 0.10% +0.081 pp | 0.00% +0.003 pp | USD1.49 +4.7% | 4 qtrs — |
| 58 | RHUMBLINE ADVISERS | 101.9K -12.3K (-10.8%) | 159.0K -179.2K (-53.0%) | 0.10% -0.015 pp | 0.00% 0.000 pp | USD12.41 -87.4% | 27 qtrs — |
| 59 | JASPER RIDGE PARTNERS, L.P. | 95.1K +23.3K (+32.5%) | 148.3K -64.2K (-30.2%) | 0.09% +0.021 pp | 0.00% -0.002 pp | USD3.41 -54.3% | 10 qtrs — |
| 60 | ALLIANCEBERNSTEIN L.P. | 92.9K +— (+0.0%) | 145.0K -130.1K (-47.3%) | 0.09% -0.002 pp | 0.00% +0.000 pp | USD6.45 -75.8% | 27 qtrs — |
| 61 | LOS ANGELES CAPITAL MANAGEMENT LLC | 93.1K +1.8K (+2.0%) | 141.4K -128.6K (-47.6%) | 0.09% 0.000 pp | 0.00% 0.000 pp | USD3.25 -52.0% | 16 qtrs — |
| 62 | WELLS FARGO & COMPANY/MN | 90.1K +37.7K (+71.9%) | 140.6K -14.6K (-9.4%) | 0.09% +0.036 pp | 0.00% +0.000 pp | USD2.83 -44.9% | 28 qtrs — |
| 63 | MAN GROUP PLC | 86.2K +86.2K (+100.0%) | 134.4K +134.4K (+100.0%) | 0.08% +0.084 pp | 0.00% +0.000 pp | USD1.56 +0.0% | 1 qtrs NEW |
| 64 | SIMPLEX TRADING, LLC | 82.0K -18.9K (-18.8%) | 127.9K -170.1K (-57.1%) | 0.08% -0.021 pp | 0.00% 0.000 pp | USD2.96 -47.3% | 2 qtrs — |
| 65 | SQUAREPOINT OPS LLC | 77.6K +77.6K (+100.0%) | 121.1K +121.1K (+100.0%) | 0.08% +0.076 pp | 0.00% +0.000 pp | USD1.56 +0.0% | 1 qtrs NEW |
| 66 | RUSSELL INVESTMENTS GROUP, LTD. | 71.9K -32.9K (-31.4%) | 112.1K -198.1K (-63.9%) | 0.07% -0.034 pp | 0.00% 0.000 pp | USD5.08 -69.3% | 17 qtrs — |
| 67 | BLACKSTONE INC. | 66.9K +41.1K (+160.0%) | 104.3K +28.2K (+37.0%) | 0.07% +0.040 pp | 0.00% +0.000 pp | USD3.56 -56.2% | 13 qtrs — |
| 68 | QUADRATURE CAPITAL LTD | 62.3K +62.3K (+100.0%) | 97.1K +97.1K (+100.0%) | 0.06% +0.061 pp | 0.00% +0.001 pp | USD1.56 +0.0% | 1 qtrs NEW |
| 69 | HRT FINANCIAL LP | 57.3K -2.8K (-4.7%) | 89.0K -89.0K (-50.0%) | 0.06% -0.004 pp | 0.00% 0.000 pp | USD2.96 -47.3% | 2 qtrs — |
| 70 | PRICE T ROWE ASSOCIATES INC /MD/ | 56.2K -2.1M (-97.4%) | 89.0K -6.4M (-98.6%) | 0.05% -2.122 pp | 0.00% -0.001 pp | USD3.17 -50.8% | 26 qtrs — |
| 71 | SPEARS ABACUS ADVISORS LLC | 54.6K -4.6K (-7.7%) | 85.2K -90.1K (-51.4%) | 0.05% -0.006 pp | 0.00% -0.002 pp | USD6.16 -74.7% | 8 qtrs — |
| 72 | CITADEL ADVISORS LLC | 53.5K -10.4K (-16.3%) | 83.5K -105.7K (-55.9%) | 0.05% -0.012 pp | 0.00% +0.000 pp | USD2.82 -44.7% | 13 qtrs — |
| 73 | LEXINGTON PARTNERS L.P. | 53.5K +43.4K (+429.2%) | 83.4K +53.5K (+178.9%) | 0.05% +0.042 pp | 0.02% +0.016 pp | USD1.82 -14.3% | 2 qtrs — |
| 74 | VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 53.1K -5.3K (-9.0%) | 82.8K -89.9K (-52.1%) | 0.05% -0.006 pp | 0.00% -0.001 pp | USD1.61 -3.1% | 5 qtrs — |
| 75 | HSBC HOLDINGS PLC | 48.5K -145.0 (-0.3%) | 75.7K -64.0K (-45.8%) | 0.05% -0.001 pp | 0.00% +0.000 pp | USD5.62 -72.2% | 15 qtrs — |
| 76 | OXFORD ASSET MANAGEMENT LLP | 42.9K +42.9K (+100.0%) | 66.9K +66.9K (+100.0%) | 0.04% +0.042 pp | 0.03% +0.027 pp | USD1.56 +0.0% | 1 qtrs NEW |
| 77 | TUDOR INVESTMENT CORP ET AL | 41.3K +— (+0.0%) | 64.4K -57.8K (-47.3%) | 0.04% -0.001 pp | 0.00% 0.000 pp | USD1.90 -17.9% | 7 qtrs — |
| 78 | TOWER RESEARCH CAPITAL LLC (TRC) | 39.5K +37.0K (+1,472.0%) | 61.7K +54.2K (+728.5%) | 0.04% +0.036 pp | 0.00% +0.001 pp | USD1.63 -4.3% | 28 qtrs — |
| 79 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 37.3K +5.1K (+16.0%) | 58.1K -37.0K (-38.9%) | 0.04% +0.004 pp | 0.00% 0.000 pp | USD3.99 -60.9% | 7 qtrs — |
| 80 | INTECH INVESTMENT MANAGEMENT LLC | 34.5K +1.1K (+3.2%) | 53.8K -45.1K (-45.6%) | 0.03% +0.000 pp | 0.00% 0.000 pp | USD2.46 -36.6% | 6 qtrs — |
| 81 | JPMORGAN CHASE & CO | 32.6K -103.8K (-76.1%) | 50.9K -352.8K (-87.4%) | 0.03% -0.104 pp | 0.00% +0.000 pp | USD6.58 -76.3% | 28 qtrs — |
| 82 | PRUDENTIAL FINANCIAL INC | 32.2K +4.2K (+15.0%) | 50.3K -32.7K (-39.4%) | 0.03% +0.004 pp | 0.00% +0.000 pp | USD1.75 -10.9% | 3 qtrs — |
| 83 | VONTOBEL HOLDING LTD. | 30.0K +4.0K (+15.4%) | 46.8K -30.2K (-39.2%) | 0.03% +0.003 pp | 0.00% 0.000 pp | USD2.82 -44.7% | 10 qtrs — |
| 84 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 28.8K -187.7K (-86.7%) | 45.0K -596.1K (-93.0%) | 0.03% -0.188 pp | 0.00% -0.001 pp | USD5.56 -71.9% | 26 qtrs — |
| 85 | SG AMERICAS SECURITIES, LLC | 27.0K +27.0K (+100.0%) | 42.0K +42.0K (+100.0%) | 0.03% +0.026 pp | 0.00% +0.000 pp | USD1.56 +0.0% | 1 qtrs NEW |
| 86 | DYNAMIC TECHNOLOGY LAB PRIVATE LTD | 25.9K +25.9K (+100.0%) | 40.0K +40.0K (+100.0%) | 0.03% +0.025 pp | 0.01% +0.009 pp | USD1.56 +0.0% | 1 qtrs NEW |
| 87 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 23.4K +— (+0.0%) | 36.5K -32.8K (-47.3%) | 0.02% -0.001 pp | 0.00% 0.000 pp | USD2.18 -28.4% | 5 qtrs — |
| 88 | POINT72 ASSET MANAGEMENT, L.P. | 23.1K +22.6K (+4,162.4%) | 36.0K +34.4K (+2,145.4%) | 0.02% +0.022 pp | 0.00% +0.000 pp | USD1.59 -1.9% | 2 qtrs — |
| 89 | BNP PARIBAS ARBITRAGE, SNC | 22.4K +4.1K (+22.5%) | 34.9K -19.2K (-35.4%) | 0.02% +0.004 pp | 0.00% +0.000 pp | USD2.48 -37.1% | 27 qtrs — |
| 90 | VIRTU FINANCIAL LLC | 21.9K +21.9K (+100.0%) | 34.0K +34.0K (+100.0%) | 0.02% +0.021 pp | 0.00% +0.001 pp | USD1.56 +0.0% | 1 qtrs NEW |
| 91 | HERSHEY TRUST CO | 20.6K +10.3K (+100.0%) | 32.1K +1.6K (+5.4%) | 0.02% +0.010 pp | 0.00% +0.000 pp | USD2.26 -31.0% | 2 qtrs — |
| 92 | BRONTE CAPITAL MANAGEMENT PTY LTD. | 19.3K +19.3K (+100.0%) | 30.1K +30.1K (+100.0%) | 0.02% +0.019 pp | 0.00% +0.003 pp | USD1.56 +0.0% | 1 qtrs NEW |
| 93 | SEI INVESTMENTS CO | 16.9K +— (+0.0%) | 26.3K -23.6K (-47.3%) | 0.02% 0.000 pp | 0.00% +0.000 pp | USD1.23 +26.8% | 4 qtrs — |
| 94 | PROSHARE ADVISORS LLC | 14.7K -759.0 (-4.9%) | 22.9K -22.8K (-49.9%) | 0.01% -0.001 pp | 0.00% 0.000 pp | USD9.71 -83.9% | 25 qtrs — |
| 95 | NEUBERGER BERMAN GROUP LLC | 14.2K +14.2K (+100.0%) | 22.1K +22.1K (+100.0%) | 0.01% +0.014 pp | 0.00% +0.000 pp | USD1.56 +0.0% | 1 qtrs NEW |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 53 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Lazard Emerging Markets Opportunities ETF EMKT | 0.50% | 845.1K | 0.74% |
| 2 | Xtrackers LPX Private Equity Swap UCITS ETF 1C XLPE.L | 0.49% | 1.56M | 0.70% |
| 3 | Invesco NASDAQ Future Gen 200 ETF QQQS | 0.37% | 81.8K | 0.20% |
| 4 | iShares Micro-Cap ETF IWC | 0.04% | 531.6K | 0.60% |
| 5 | Avantis Emerging Markets Value ETF AVES | 0.02% | 302.4K | 0.36% |
| 6 | Avantis Emerging Markets Equity UCITS ETF USD Acc AVEM.L | 0.01% | 36.8K | 0.35% |
| 7 | Vanguard Russell 2000 Value ETF VTWV | 0.01% | 143.0K | 0.06% |
| 8 | Invesco RAFI US 1500 Small-Mid ETF PRFZ | 0.01% | 249.2K | 0.34% |
| 9 | iShares Russell 2000 Growth ETF IWO | 0.01% | 1.33M | 0.24% |
| 10 | Xtrackers Russell 2000 UCITS ETF 1C XRSU.L | 0.01% | 210.2K | 0.30% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Ratio by volume
0.00
Bearish
Buys
0
Sells
1
Shares acquired
—
Shares disposed
1.8K
Cash buys
—
Cash sales
1.00
Net activity
-1,820
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-16 | Wong-Sarad Grace | Officer | S-Sale | D | Common Stock | 1,820 | 2.65 | 4.8K | 104,645 | D | ↗ |
| 2026-03-15 | Berkley Neil Lindsay | Officer | A-Award | A | Common Stock | 54,600 | 0.00 | — | 399,260 | D | ↗ |
| 2026-03-13 | Rosenthal Arnon | Director / Officer | A-Award | A | Common Stock | 116,246 | 0.00 | — | 2,454,422 | D | ↗ |
| 2026-03-10 | Wong-Sarad Grace | Officer | S-Sale | D | Common Stock | 1,000 | 2.65 | 2.7K | 106,465 | D | ↗ |
| 2026-03-03 | Wong-Sarad Grace | Officer | S-Sale | D | Common Stock | 3,367 | 2.08 | 7.0K | 107,465 | D | ↗ |
| 2026-03-02 | Wong-Sarad Grace | Officer | S-Sale | D | Common Stock | 8,071 | 2.12 | 17.1K | 110,832 | D | ↗ |
| 2026-03-02 | Rosenthal Arnon | Director / Officer | S-Sale | D | Common Stock | 81,864 | 2.12 | 173.8K | 2,338,176 | D | ↗ |
| 2026-03-02 | Berkley Neil Lindsay | Officer | S-Sale | D | Common Stock | 29,649 | 2.12 | 63.0K | 344,660 | D | ↗ |
| 2026-02-26 | Wong-Sarad Grace | Officer | S-Sale | D | Common Stock | 4,079 | 2.50 | 10.2K | 118,903 | D | ↗ |
| 2025-12-05 | Wong-Sarad Grace | Officer | S-Sale | D | Common Stock | 4,753 | 1.21 | 5.8K | 122,982 | D | ↗ |
| 2025-12-03 | Wong-Sarad Grace | Officer | S-Sale | D | Common Stock | 8,056 | 1.12 | 9.0K | 127,735 | D | ↗ |
| 2025-12-03 | Rosenthal Arnon | Director / Officer | S-Sale | D | Common Stock | 104,347 | 1.12 | 116.8K | 2,420,040 | D | ↗ |
| 2025-12-03 | Kenkare-Mitra Sara | Officer | S-Sale | D | Common Stock | 41,687 | 1.12 | 46.7K | 501,652 | D | ↗ |
| 2025-12-03 | Berkley Neil Lindsay | Officer | S-Sale | D | Common Stock | 37,261 | 1.12 | 41.7K | 374,309 | D | ↗ |
| 2025-11-10 | Wong-Sarad Grace | Officer | A-Award | A | Common Stock | 32,343 | 0.00 | — | 135,791 | D | ↗ |
| 2025-11-10 | Rosenthal Arnon | Director / Officer | A-Award | A | Common Stock | 174,167 | 0.00 | — | 2,524,387 | D | ↗ |
| 2025-11-10 | Berkley Neil Lindsay | Officer | A-Award | A | Common Stock | 65,000 | 0.00 | — | 411,570 | D | ↗ |
| 2025-09-02 | Wong-Sarad Grace | Officer | S-Sale | D | Common Stock | 5,910 | 2.50 | 14.8K | 103,448 | D | ↗ |
| 2025-09-02 | Rosenthal Arnon | Director / Officer | S-Sale | D | Common Stock | 51,562 | 2.50 | 128.7K | 2,350,220 | D | ↗ |
| 2025-09-02 | Kenkare-Mitra Sara | Officer | S-Sale | D | Common Stock | 23,638 | 2.50 | 59.0K | 543,339 | D | ↗ |
| 2025-09-02 | Berkley Neil Lindsay | Officer | S-Sale | D | Common Stock | 15,842 | 2.50 | 39.6K | 346,570 | D | ↗ |
| 2025-08-26 | Hammond Paula | Director | S-Sale | D | Common Stock | 14,000 | 2.36 | 33.0K | 74,909 | D | ↗ |
| 2025-07-01 | Rosenthal Arnon | Director / Officer | A-Award | A | Common Stock | 137,125 | 0.00 | — | 2,551,782 | D | ↗ |
| 2025-07-01 | Kenkare-Mitra Sara | Officer | A-Award | A | Common Stock | 54,725 | 0.00 | — | 566,977 | D | ↗ |
| 2025-07-01 | Berkley Neil Lindsay | Officer | A-Award | A | Employee Stock Option (right to buy) | 18,000 | 1.42 | 25.6K | 18,000 | D | ↗ |
| 2025-06-20 | Yaffe Kristine | Director | S-Sale | D | Common Stock | 1,000 | 1.44 | 1.4K | 95,409 | D | ↗ |
| 2025-06-20 | Wong-Sarad Grace | Officer | — | — | Employee Stock Option (right to buy) | 11,309 | 9.46 | 107.0K | 0 | D | ↗ |
| 2025-06-20 | Berkley Neil Lindsay | Officer | — | — | Employee Stock Option (right to buy) | 12,975 | 1.11 | 14.3K | 0 | D | ↗ |
| 2025-06-11 | Yaffe Kristine | Director | A-Award | A | Stock Option (right to buy) | 9,450 | 1.63 | 15.4K | 9,450 | D | ↗ |
| 2025-06-11 | SCHELLER RICHARD H | Director | A-Award | A | Stock Option (right to buy) | 9,450 | 1.63 | 15.4K | 9,450 | D | ↗ |
| 2025-06-11 | LAVIGNE LOUIS J JR | Director | A-Award | A | Stock Option (right to buy) | 9,450 | 1.63 | 15.4K | 9,450 | D | ↗ |
| 2025-06-11 | Hammond Paula | Director | A-Award | A | Stock Option (right to buy) | 9,450 | 1.63 | 15.4K | 9,450 | D | ↗ |
| 2025-06-11 | GAROFALO ELIZABETH A. | Director | A-Award | A | Common Stock | 28,700 | 0.00 | — | 89,950 | D | ↗ |
| 2025-06-11 | DESOUZA ERROL B | Director | A-Award | A | Stock Option (right to buy) | 9,450 | 1.63 | 15.4K | 9,450 | D | ↗ |
| 2025-06-11 | Altmeyer Mark | Director | A-Award | A | Stock Option (right to buy) | 9,450 | 1.63 | 15.4K | 9,450 | D | ↗ |
| 2025-06-02 | Rosenthal Arnon | Director / Officer | S-Sale | D | Common Stock | 52,087 | 1.34 | 69.7K | 2,414,657 | D | ↗ |
| 2025-06-02 | Kenkare-Mitra Sara | Officer | S-Sale | D | Common Stock | 23,890 | 1.34 | 32.0K | 512,252 | D | ↗ |
| 2025-06-02 | GRASSO MARC | Officer | S-Sale | D | Common Stock | 16,488 | 1.34 | 22.1K | 296,072 | D | ↗ |
| 2025-05-02 | SCHELLER RICHARD H | Director | A-Award | A | Common Stock | 15,833 | 0.00 | — | 66,666 | D | ↗ |
| 2025-03-03 | Rosenthal Arnon | Director / Officer | S-Sale | D | Common Stock | 40,330 | 1.47 | 59.2K | 2,466,744 | D | ↗ |
| 2025-03-03 | Romano Gary | Officer | S-Sale | D | Common Stock | 16,306 | 1.47 | 23.9K | 332,977 | D | ↗ |
| 2025-03-03 | Kenkare-Mitra Sara | Officer | S-Sale | D | Common Stock | 29,073 | 1.47 | 42.7K | 536,142 | D | ↗ |
| 2025-03-03 | GRASSO MARC | Officer | S-Sale | D | Common Stock | 18,091 | 1.47 | 26.5K | 312,560 | D | ↗ |
| 2024-12-02 | Rosenthal Arnon | Director / Officer | S-Sale | D | Common Stock | 52,172 | 2.52 | 131.4K | 2,507,074 | D | ↗ |
| 2024-12-02 | Romano Gary | Officer | S-Sale | D | Common Stock | 14,892 | 2.52 | 37.5K | 349,283 | D | ↗ |
| 2024-12-02 | Kenkare-Mitra Sara | Officer | S-Sale | D | Common Stock | 26,500 | 2.52 | 66.8K | 565,215 | D | ↗ |
| 2024-12-02 | GRASSO MARC | Officer | S-Sale | D | Common Stock | 16,489 | 2.52 | 41.5K | 330,651 | D | ↗ |
| 2024-10-01 | Rosenthal Arnon | Director / Officer | A-Award | A | Common Stock | 610,500 | 0.00 | — | 2,559,246 | D | ↗ |
| 2024-10-01 | Romano Gary | Officer | A-Award | A | Common Stock | 184,380 | 0.00 | — | 364,175 | D | ↗ |
| 2024-10-01 | Kenkare-Mitra Sara | Officer | A-Award | A | Common Stock | 300,000 | 0.00 | — | 591,715 | D | ↗ |
| 2024-10-01 | GRASSO MARC | Officer | A-Award | A | Common Stock | 216,400 | 0.00 | — | 347,140 | D | ↗ |
| 2024-09-03 | Rosenthal Arnon | Director / Officer | S-Sale | D | Common Stock | 26,499 | 4.88 | 129.4K | 1,948,746 | — | ↗ |
| 2024-09-03 | Romano Gary | Officer | S-Sale | D | Common Stock | 8,478 | 4.88 | 41.4K | 179,795 | — | ↗ |
| 2024-09-03 | Kenkare-Mitra Sara | Officer | S-Sale | D | Common Stock | 13,926 | 4.88 | 68.0K | 291,715 | — | ↗ |
| 2024-09-03 | GRASSO MARC | Officer | S-Sale | D | Common Stock | 7,297 | 4.88 | 35.6K | 130,740 | — | ↗ |
| 2024-08-22 | SCHELLER RICHARD H | Director | S-Sale | D | Common Stock | 44,250 | 5.16 | 228.4K | 35,000 | — | ↗ |
| 2024-08-12 | Yaffe Kristine | Director | S-Sale | D | Common Stock | 5,000 | 5.06 | 25.3K | 67,709 | — | ↗ |
| 2024-08-12 | Hammond Paula | Director | S-Sale | D | Common Stock | 10,500 | 5.06 | 53.2K | 60,209 | — | ↗ |
| 2024-08-02 | SCHELLER RICHARD H | Director | A-Award | A | Common Stock | 15,833 | 0.00 | — | 50,833 | D | ↗ |
| 2024-06-12 | Yaffe Kristine | Director | A-Award | A | Common Stock | 35,000 | 0.00 | — | 72,709 | — | ↗ |
| 2024-06-12 | Wehner David M. | Director | A-Award | A | Common Stock | 35,000 | 0.00 | — | 115,330 | — | ↗ |
| 2024-06-12 | SCHELLER RICHARD H | Director | A-Award | A | Common Stock | 35,000 | 0.00 | — | 79,250 | — | ↗ |
| 2024-06-12 | LAVIGNE LOUIS J JR | Director | A-Award | A | Common Stock | 35,000 | 0.00 | — | 70,709 | — | ↗ |
| 2024-06-12 | Hammond Paula | Director | A-Award | A | Common Stock | 35,000 | 0.00 | — | 70,709 | — | ↗ |
| 2024-06-12 | GAROFALO ELIZABETH A. | Director | A-Award | A | Common Stock | 35,000 | 0.00 | — | 61,250 | — | ↗ |
| 2024-06-03 | Rosenthal Arnon | Director / Officer | S-Sale | D | Common Stock | 25,135 | 4.80 | 120.6K | 1,975,245 | — | ↗ |
| 2024-06-03 | Romano Gary | Officer | S-Sale | D | Common Stock | 8,040 | 4.80 | 38.6K | 188,273 | — | ↗ |
| 2024-06-03 | Kenkare-Mitra Sara | Officer | S-Sale | D | Common Stock | 13,206 | 4.80 | 63.4K | 305,641 | — | ↗ |
| 2024-06-03 | GRASSO MARC | Officer | S-Sale | D | Common Stock | 6,920 | 4.80 | 33.2K | 138,037 | — | ↗ |
| 2024-05-29 | Polaris Venture Management Co. VI, L.L.C. | 10% Owner | J-Other | D | Common Stock | 500,000 | 0.00 | — | 9,853,817 | — | ↗ |
| 2024-04-30 | Polaris Venture Management Co. VI, L.L.C. | 10% Owner | J-Other | D | Common Stock | 500,000 | 0.00 | — | 10,353,817 | — | ↗ |
| 2024-03-19 | DESOUZA ERROL B | Director | A-Award | A | Stock Option (right to buy) | 19,420 | 6.20 | 120.4K | 19,420 | — | ↗ |
| 2024-03-19 | Altmeyer Mark | Director | — | D | No securities of the Issuer are beneficially owned. | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-03-04 | Rosenthal Arnon | Director / Officer | S-Sale | D | Common Stock | 18,837 | 6.92 | 130.4K | 2,000,380 | — | ↗ |
| 2024-03-04 | Romano Gary | Officer | S-Sale | D | Common Stock | 6,001 | 6.92 | 41.6K | 196,313 | — | ↗ |
| 2024-03-04 | Kenkare-Mitra Sara | Officer | S-Sale | D | Common Stock | 10,169 | 6.92 | 70.4K | 318,847 | — | ↗ |
| 2024-03-04 | GRASSO MARC | Officer | S-Sale | D | Common Stock | 5,716 | 6.92 | 39.6K | 144,957 | — | ↗ |
| 2023-12-05 | GAROFALO ELIZABETH A. | Director | G-Gift | D | Common Stock | 9,459 | 0.00 | — | 26,250 | — | ↗ |
| 2023-12-04 | Rosenthal Arnon | Director / Officer | S-Sale | D | Common Stock | 23,831 | 5.56 | 132.5K | 2,019,217 | — | ↗ |
| 2023-12-04 | Romano Gary | Officer | S-Sale | D | Common Stock | 5,035 | 5.56 | 28.0K | 202,314 | — | ↗ |
| 2023-12-04 | Kenkare-Mitra Sara | Officer | S-Sale | D | Common Stock | 12,519 | 5.56 | 69.6K | 329,016 | — | ↗ |
| 2023-12-04 | GRASSO MARC | Officer | S-Sale | D | Common Stock | 4,574 | 5.56 | 25.4K | 150,673 | — | ↗ |
| 2023-10-01 | Rosenthal Arnon | Director / Officer | A-Award | A | Common Stock | 397,600 | 0.00 | — | 2,043,048 | — | ↗ |
| 2023-10-01 | Romano Gary | Officer | A-Award | A | Common Stock | 108,000 | 0.00 | — | 207,349 | — | ↗ |
| 2023-10-01 | Kenkare-Mitra Sara | Officer | A-Award | A | Common Stock | 163,600 | 0.00 | — | 341,535 | — | ↗ |
| 2023-10-01 | GRASSO MARC | Officer | A-Award | A | Common Stock | 123,000 | 0.00 | — | 155,247 | — | ↗ |
| 2023-09-11 | Polaris Venture Management Co. VI, L.L.C. | 10% Owner | S-Sale | D | Common Stock | 500,000 | 6.00 | 3.00M | 10,853,817 | — | ↗ |
| 2023-09-11 | MCGUIRE TERRANCE | Director / 10% Owner | S-Sale | D | Common Stock | 500,000 | 6.00 | 3.00M | 10,853,817 | — | ↗ |
| 2023-09-05 | Rosenthal Arnon | Director / Officer | S-Sale | D | Common Stock | 5,647 | 5.19 | 29.3K | 1,645,448 | — | ↗ |
| 2023-09-05 | Romano Gary | Officer | S-Sale | D | Common Stock | 2,771 | 5.19 | 14.4K | 99,349 | — | ↗ |
| 2023-09-05 | Kenkare-Mitra Sara | Officer | S-Sale | D | Common Stock | 6,214 | 5.19 | 32.3K | 177,935 | — | ↗ |
| 2023-09-05 | GRASSO MARC | Officer | S-Sale | D | Common Stock | 1,114 | 5.19 | 5.8K | 32,247 | — | ↗ |
| 2023-08-22 | Polaris Venture Management Co. VI, L.L.C. | 10% Owner | J-Other | A | Common Stock | 98,533 | 0.00 | — | 98,533 | — | ↗ |
| 2023-08-22 | MCGUIRE TERRANCE | Director / 10% Owner | J-Other | D | Common Stock | 98,533 | 0.00 | — | 0 | — | ↗ |
| 2023-07-15 | SCHELLER RICHARD H | Director | A-Award | A | Common Stock | 8,541 | 0.00 | — | 44,250 | — | ↗ |
| 2023-06-14 | Yaffe Kristine | Director | A-Award | A | Stock Option (right to buy) | 12,360 | 7.71 | 95.3K | 12,360 | — | ↗ |
| 2023-06-14 | Wehner David M. | Director | A-Award | A | Common Stock | 26,250 | 0.00 | — | 80,330 | — | ↗ |
| 2023-06-14 | SCHELLER RICHARD H | Director | A-Award | A | Stock Option (right to buy) | 12,360 | 7.71 | 95.3K | 12,360 | — | ↗ |
| 2023-06-14 | MCGUIRE TERRANCE | Director / 10% Owner | A-Award | A | Stock Option (right to buy) | 12,360 | 7.71 | 95.3K | 12,360 | — | ↗ |
| 2023-06-14 | LAVIGNE LOUIS J JR | Director | A-Award | A | Stock Option (right to buy) | 12,360 | 7.71 | 95.3K | 12,360 | — | ↗ |
| 2023-06-14 | Hammond Paula | Director | A-Award | A | Stock Option (right to buy) | 12,360 | 7.71 | 95.3K | 12,360 | — | ↗ |
| 2023-06-14 | Gerngross Tillman U. | Director | A-Award | A | Stock Option (right to buy) | 12,360 | 7.71 | 95.3K | 12,360 | — | ↗ |
| 2023-06-14 | GAROFALO ELIZABETH A. | Director | A-Award | A | Stock Option (right to buy) | 12,360 | 7.71 | 95.3K | 12,360 | — | ↗ |
| 2023-06-02 | Rosenthal Arnon | Director / Officer | S-Sale | D | Common Stock | 5,255 | 6.90 | 36.3K | 1,651,095 | — | ↗ |
| 2023-06-02 | Romano Gary | Officer | S-Sale | D | Common Stock | 2,617 | 6.90 | 18.1K | 102,120 | — | ↗ |
| 2023-06-02 | Kenkare-Mitra Sara | Officer | S-Sale | D | Common Stock | 4,092 | 6.90 | 28.2K | 184,149 | — | ↗ |
| 2023-06-02 | GRASSO MARC | Officer | S-Sale | D | Common Stock | 1,050 | 6.90 | 7.2K | 33,361 | — | ↗ |
| 2023-03-17 | Rosenthal Arnon | Director / Officer | S-Sale | D | Common Stock | 15,186 | 6.22 | 94.4K | 1,656,350 | — | ↗ |
| 2023-03-03 | Rosenthal Arnon | Director / Officer | A-Award | A | Common Stock | 42,990 | 0.00 | — | 1,671,536 | — | ↗ |
| 2023-03-02 | Rosenthal Arnon | Director / Officer | S-Sale | D | Common Stock | 5,849 | 8.32 | 48.7K | 1,628,546 | — | ↗ |
| 2023-03-02 | Romano Gary | Officer | S-Sale | D | Common Stock | 3,238 | 8.32 | 26.9K | 104,737 | — | ↗ |
| 2023-03-02 | Kenkare-Mitra Sara | Officer | S-Sale | D | Common Stock | 10,124 | 8.32 | 84.2K | 188,241 | — | ↗ |
| 2023-03-02 | GRASSO MARC | Officer | S-Sale | D | Common Stock | 1,291 | 8.32 | 10.7K | 34,411 | — | ↗ |
| 2022-12-02 | Romano Gary | Officer | S-Sale | D | Common Stock | 2,145 | 8.71 | 18.7K | 107,975 | — | ↗ |
| 2022-11-16 | Polaris Venture Management Co. VI, L.L.C. | Director | J-Other | D | Common Stock | 98,533 | 0.00 | — | 0 | — | ↗ |
| 2022-11-16 | MCGUIRE TERRANCE | Director | J-Other | A | Common Stock | 13,133 | 0.00 | — | 26,266 | — | ↗ |
| 2022-10-01 | Rosenthal Arnon | Officer | A-Award | A | Common Stock | 179,169 | 0.00 | — | 1,634,395 | — | ↗ |
| 2022-10-01 | Romano Gary | Officer | A-Award | A | Common Stock | 20,047 | 0.00 | — | 110,120 | — | ↗ |
| 2022-10-01 | King Robert | Officer | A-Award | A | Employee Stock Option (right to buy) | 14,384 | 0.00 | — | 14,384 | — | ↗ |
| 2022-10-01 | Kenkare-Mitra Sara | Officer | A-Award | A | Employee Stock Option (right to buy) | 53,576 | 0.00 | — | 53,576 | — | ↗ |
| 2022-10-01 | GRASSO MARC | Officer | A-Award | A | Employee Stock Option (right to buy) | 23,801 | 0.00 | — | 23,801 | — | ↗ |
| 2022-09-02 | Romano Gary | Officer | S-Sale | D | Common Stock | 2,177 | 10.62 | 23.1K | 90,073 | — | ↗ |
| 2022-09-02 | King Robert | Officer | S-Sale | D | Common Stock | 176 | 10.62 | 1.9K | 529,295 | — | ↗ |
| 2022-06-16 | Yaffe Kristine | Director | A-Award | A | Common Stock | 9,459 | 0.00 | — | 9,459 | — | ↗ |
| 2022-06-16 | Wehner David M. | Director | A-Award | A | Stock Option (right to buy) | 18,918 | 8.07 | 152.7K | 18,918 | — | ↗ |
| 2022-06-16 | SCHELLER RICHARD H | Director | A-Award | A | Common Stock | 9,459 | 0.00 | — | 9,459 | — | ↗ |
| 2022-06-16 | MCGUIRE TERRANCE | Director | A-Award | A | Stock Option (right to buy) | 18,918 | 8.07 | 152.7K | 18,918 | — | ↗ |
| 2022-06-16 | LAVIGNE LOUIS J JR | Director | A-Award | A | Common Stock | 9,459 | 0.00 | — | 9,459 | — | ↗ |
| 2022-06-16 | Hammond Paula | Director | A-Award | A | Common Stock | 9,459 | 0.00 | — | 9,459 | — | ↗ |
| 2022-06-16 | Gerngross Tillman U. | Director | A-Award | A | Stock Option (right to buy) | 18,918 | 8.07 | 152.7K | 18,918 | — | ↗ |
| 2022-06-16 | GAROFALO ELIZABETH A. | Director | A-Award | A | Common Stock | 9,459 | 0.00 | — | 9,459 | — | ↗ |
| 2022-06-02 | King Robert | Officer | S-Sale | D | Common Stock | 177 | 8.71 | 1.5K | 529,471 | — | ↗ |
| 2022-05-27 | Romano Gary | Officer | A-Award | A | Common Stock | 92,250 | 0.00 | — | 92,250 | — | ↗ |
| 2022-05-23 | Romano Gary | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-03-01 | King Robert | Officer | S-Sale | D | Common Stock | 287 | 15.57 | 4.5K | 528,404 | — | ↗ |
| 2022-03-01 | GRASSO MARC | Officer | A-Award | A | Employee Stock Option (right to buy) | 450,000 | 15.49 | 6.97M | 450,000 | — | ↗ |
| 2022-02-07 | GRASSO MARC | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-01-03 | Kenkare-Mitra Sara | Officer | A-Award | A | Employee Stock Option (right to buy) | 300,000 | 20.78 | 6.23M | 300,000 | — | ↗ |
| 2021-12-21 | Polaris Venture Management Co. VI, L.L.C. | 10% Owner | J-Other | D | Common Stock | 98,533 | 0.00 | — | 0 | — | ↗ |
| 2021-12-21 | MCGUIRE TERRANCE | Director / 10% Owner | J-Other | D | Common Stock | 98,533 | 0.00 | — | 0 | — | ↗ |
| 2021-12-15 | Kenkare-Mitra Sara | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-13 | SULIMAN SHEHNAAZ | Officer | M-Exempt | A | Common Stock | 75,000 | 17.23 | 1.29M | 177,598 | — | ↗ |
| 2021-12-10 | SULIMAN SHEHNAAZ | Officer | M-Exempt | D | Employee Stock Option (right to buy) | 75,000 | 17.23 | 1.29M | 380,187 | — | ↗ |
| 2021-12-09 | SULIMAN SHEHNAAZ | Officer | M-Exempt | A | Common Stock | 75,000 | 17.23 | 1.29M | 177,598 | — | ↗ |
| 2021-12-08 | SULIMAN SHEHNAAZ | Officer | S-Sale | D | Common Stock | 36,511 | 22.56 | 823.6K | 141,087 | — | ↗ |
| 2021-12-01 | King Robert | Officer | S-Sale | D | Common Stock | 250 | 20.09 | 5.0K | 528,691 | — | ↗ |
| 2021-11-11 | Rosenthal Arnon | Director / Officer | S-Sale | D | Common Stock | 55,000 | 25.00 | 1.38M | 1,972,875 | — | ↗ |
| 2021-11-10 | Rosenthal Arnon | Director / Officer | S-Sale | D | Common Stock | 55,000 | 25.00 | 1.38M | 2,027,875 | — | ↗ |
| 2021-11-09 | Rosenthal Arnon | Director / Officer | S-Sale | D | Common Stock | 15,000 | 25.00 | 375.0K | 652,500 | — | ↗ |
| 2021-11-08 | Rosenthal Arnon | Director / Officer | S-Sale | D | Common Stock | 55,000 | 25.00 | 1.38M | 2,137,875 | — | ↗ |
| 2021-11-05 | Rosenthal Arnon | Director / Officer | S-Sale | D | Common Stock | 55,000 | 25.00 | 1.38M | 2,192,875 | — | ↗ |
| 2021-11-04 | Rosenthal Arnon | Director / Officer | S-Sale | D | Common Stock | 55,000 | 25.00 | 1.38M | 2,247,875 | — | ↗ |
| 2021-10-01 | Rosenthal Arnon | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 417,213 | 23.70 | 9.89M | 417,213 | — | ↗ |
| 2021-10-01 | King Robert | Officer | A-Award | A | Common Stock | 5,939 | 0.00 | — | 528,256 | — | ↗ |
| 2021-09-23 | Rosenthal Arnon | Director / Officer | S-Sale | D | Common Stock | 9,625 | 25.10 | 241.6K | 2,302,875 | — | ↗ |
| 2021-09-23 | GAROFALO ELIZABETH A. | Director | A-Award | A | Stock Option (right to buy) | 33,235 | 24.26 | 806.3K | 33,235 | — | ↗ |
| 2021-09-22 | Rosenthal Arnon | Director / Officer | S-Sale | D | Common Stock | 5,283 | 26.10 | 137.9K | 2,312,500 | — | ↗ |
| 2021-09-21 | Rosenthal Arnon | Director / Officer | S-Sale | D | Common Stock | 8,462 | 26.56 | 224.7K | 2,412,500 | — | ↗ |
| 2021-09-20 | Rosenthal Arnon | Director / Officer | S-Sale | D | Common Stock | 8,046 | 26.33 | 211.8K | 2,512,500 | — | ↗ |
| 2021-09-10 | Yaffe Kristine | Director | M-Exempt | D | Stock Option (right to buy) | 2,000 | 18.10 | 36.2K | 38,000 | — | ↗ |
| 2021-09-08 | Rubinstein Linda M | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-08-09 | Paul Robert | Officer | S-Sale | D | Common Stock | 22,650 | 27.17 | 615.4K | 234,619 | — | ↗ |
| 2021-08-05 | SCHELLER RICHARD H | Director | M-Exempt | A | Common Stock | 56,260 | 10.14 | 570.5K | 56,260 | — | ↗ |
| 2021-07-07 | Paul Robert | Officer | M-Exempt | A | Common Stock | 11,883 | 10.14 | 120.5K | 253,494 | — | ↗ |
| 2021-07-06 | Yu Calvin | Officer | M-Exempt | D | Employee Stock Option (right to buy) | 625 | 10.14 | 6.3K | 10,000 | — | ↗ |
| 2021-07-06 | Paul Robert | Officer | M-Exempt | A | Common Stock | 30,000 | 17.15 | 514.5K | 264,319 | — | ↗ |
| 2021-07-02 | Yu Calvin | Officer | S-Sale | D | Common Stock | 20,000 | 40.02 | 800.3K | 76,686 | — | ↗ |
| 2021-07-02 | SCHELLER RICHARD H | Director | S-Sale | D | Common Stock | 9,981 | 31.14 | 310.8K | 0 | — | ↗ |
| 2021-07-02 | Paul Robert | Officer | S-Sale | D | Common Stock | 30,000 | 31.14 | 934.2K | 234,319 | — | ↗ |
| 2021-07-02 | King Robert | Officer | M-Exempt | D | Employee Stock Option (right to buy) | 30,000 | 10.14 | 304.2K | 70,000 | — | ↗ |
| 2021-07-01 | Paul Robert | Officer | S-Sale | D | Common Stock | 26,726 | 22.23 | 594.1K | 246,993 | — | ↗ |
| 2021-06-17 | Yaffe Kristine | Director | A-Award | A | Stock Option (right to buy) | 25,709 | 21.37 | 549.4K | 25,709 | — | ↗ |
| 2021-06-17 | Wehner David M. | Director | A-Award | A | Stock Option (right to buy) | 25,709 | 21.37 | 549.4K | 25,709 | — | ↗ |
| 2021-06-17 | SCHELLER RICHARD H | Director | A-Award | A | Stock Option (right to buy) | 25,709 | 21.37 | 549.4K | 25,709 | — | ↗ |
| 2021-06-17 | MCGUIRE TERRANCE | Director | A-Award | A | Stock Option (right to buy) | 25,709 | 21.37 | 549.4K | 25,709 | — | ↗ |
| 2021-06-17 | LAVIGNE LOUIS J JR | Director | A-Award | A | Stock Option (right to buy) | 25,709 | 21.37 | 549.4K | 25,709 | — | ↗ |
| 2021-06-17 | Hammond Paula | Director | A-Award | A | Stock Option (right to buy) | 25,709 | 21.37 | 549.4K | 25,709 | — | ↗ |
| 2021-06-17 | Gerngross Tillman U. | Director | A-Award | A | Stock Option (right to buy) | 25,709 | 21.37 | 549.4K | 25,709 | — | ↗ |
| 2021-06-16 | Paul Robert | Officer | M-Exempt | D | Employee Stock Option (right to buy) | 4,600 | 10.14 | 46.6K | 51,867 | — | ↗ |
| 2021-06-15 | Paul Robert | Officer | M-Exempt | A | Common Stock | 17,100 | 8.16 | 139.5K | 290,819 | — | ↗ |
| 2021-06-08 | Paul Robert | Officer | M-Exempt | D | Employee Stock Option (right to buy) | 11,883 | 10.14 | 120.5K | 42,284 | — | ↗ |
| 2021-06-02 | Yu Calvin | Officer | S-Sale | D | Common Stock | 1,844 | 17.77 | 32.8K | 126,686 | — | ↗ |
| 2021-05-21 | Paul Robert | Officer | M-Exempt | A | Common Stock | 784 | 10.14 | 7.9K | 288,694 | — | ↗ |
| 2021-05-18 | Paul Robert | Officer | M-Exempt | A | Common Stock | 1,300 | 10.14 | 13.2K | 277,919 | — | ↗ |
| 2021-05-07 | Yu Calvin | Officer | A-Award | A | Common Stock | 16,000 | 0.00 | — | 126,686 | — | ↗ |
| 2021-05-07 | SULIMAN SHEHNAAZ | Officer | A-Award | A | Common Stock | 100,000 | 0.00 | — | 100,000 | — | ↗ |
| 2021-05-07 | Rosenthal Arnon | Director / Officer | A-Award | A | Common Stock | 150,000 | 0.00 | — | 1,455,226 | — | ↗ |
| 2021-05-07 | Paul Robert | Officer | A-Award | A | Common Stock | 60,000 | 0.00 | — | 273,719 | — | ↗ |
| 2021-05-07 | King Robert | Officer | A-Award | A | Common Stock | 45,000 | 0.00 | — | 522,317 | — | ↗ |
| 2021-04-07 | Paul Robert | Officer | M-Exempt | A | Common Stock | 3,125 | 17.15 | 53.6K | 236,019 | — | ↗ |
| 2021-03-23 | Paul Robert | Officer | S-Sale | D | Common Stock | 13,800 | 22.21 | 306.5K | 213,719 | — | ↗ |
| 2021-03-22 | Paul Robert | Officer | S-Sale | D | Common Stock | 5,510 | 23.55 | 129.8K | 213,719 | — | ↗ |
| 2021-03-09 | Paul Robert | Officer | M-Exempt | D | Employee Stock Option (right to buy) | 17,092 | 8.16 | 139.5K | 200,358 | — | ↗ |
| 2021-02-09 | Paul Robert | Officer | M-Exempt | A | Common Stock | 2,084 | 10.14 | 21.1K | 232,894 | — | ↗ |
| 2021-01-26 | Paul Robert | Officer | M-Exempt | D | Employee Stock Option (right to buy) | 23,142 | 8.16 | 188.8K | 234,541 | — | ↗ |
| 2021-01-25 | Paul Robert | Officer | M-Exempt | A | Common Stock | 27,916 | 8.16 | 227.8K | 241,635 | — | ↗ |
| 2021-01-20 | Paul Robert | Officer | M-Exempt | A | Common Stock | 6,484 | 8.16 | 52.9K | 220,203 | — | ↗ |
| 2021-01-19 | Paul Robert | Officer | M-Exempt | D | Employee Stock Option (right to buy) | 2,083 | 10.14 | 21.1K | 70,834 | — | ↗ |
| 2020-10-01 | Yu Calvin | Officer | A-Award | A | Stock Option (right to buy) | 67,526 | 10.24 | 691.5K | 67,526 | — | ↗ |
| 2020-10-01 | SULIMAN SHEHNAAZ | Officer | A-Award | A | Stock Option (right to buy) | 189,213 | 10.24 | 1.94M | 189,213 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-8.2K
Shares Outstanding
111.03M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Arnon Rosenthal, Ph.D. Co-founder, Chief Executive Officer | 678.1K | — | 422.9K | 558.2K | 325.5K | 10.3K | 2.00M | 49.18% | ↗ |
| 2 | 2025 | Sara Kenkare-Mitra, Ph.D. Former President and Head of Research and Development | 614.3K | — | 77.7K | 17.8K | 314.2K | 551.1K | 1.58M | 6.06% | ↗ |
| 3 | 2025 | Neil Berkley Chief Financial Officer and Chief Business Officer | 455.0K | 91.0K | 128.1K | 219.2K | 152.9K | 6.2K | 1.05M | 33.00% | ↗ |
| 4 | 2024 | Arnon Rosenthal, Ph.D. Co-founder, Chief Executive Officer | 674.8K | — | 2.78M | — | 203.4K | 10.3K | 3.67M | 75.76% | ↗ |
| 5 | 2024 | Sara Kenkare-Mitra, Ph.D. Former President and Head of Research and Development | 624.4K | — | 1.37M | — | 553.0K | 7.3K | 2.55M | 53.54% | ↗ |
| 6 | 2024 | Sara Kenkare-Mitra, Ph.D. President and Head of Research and Development | 624.4K | — | 1.37M | — | 553.0K | 7.3K | 2.55M | 53.54% | ↗ |
| 7 | 2024 | Neil Berkley Chief Financial Officer and Chief Business Officer | 350.0K | — | 1.82M | — | 117.2K | 6.0K | 2.29M | 79.34% | ↗ |
| 8 | 2024 | Marc Grasso, M.D. Chief Financial Officer | 514.8K | — | 984.6K | — | 182.2K | 6.2K | 1.69M | 58.34% | ↗ |
| 9 | 2024 | Gary Romano, M.D., Ph.D. Chief Medical Officer | 529.0K | — | 838.9K | — | 187.7K | 8.6K | 1.56M | 53.64% | ↗ |
| 10 | 2023 | Arnon Rosenthal, Ph.D. Co-founder, Chief Executive Officer | 653.6K | — | 2.58M | 614.3K | 400.0K | 10.6K | 4.26M | 74.99% | ↗ |
| 11 | 2023 | Sara Kenkare-Mitra, Ph.D. President and Head of Research and Development | 598.5K | — | 1.06M | 252.7K | 687.6K | 7.3K | 2.61M | 50.37% | ↗ |
| 12 | 2023 | Marc Grasso, M.D. Chief Financial Officer | 496.8K | — | 797.0K | 190.1K | 225.7K | 6.2K | 1.72M | 57.53% | ↗ |
| 13 | 2023 | Gary Romano, M.D., Ph.D. Chief Medical Officer | 502.3K | — | 699.8K | 166.9K | 241.3K | 8.6K | 1.62M | 53.54% | ↗ |
| 14 | 2022 | Sara Kenkare-Mitra, Ph.D. President and Head of Research and Development | 570.0K | — | 3.02M | 4.66M | 612.2K | 7.3K | 8.87M | 86.59% | ↗ |
| 15 | 2022 | Marc Grasso, M.D. Chief Financial Officer | 432.9K | 103.0K | 337.7K | 4.94M | 200.4K | 1.7K | 6.01M | 87.72% | ↗ |
| 16 | 2022 | Gary Romano, M.D., Ph.D. Chief Medical Officer | 289.9K | — | 1.04M | 2.45M | 118.7K | 7.2K | 3.91M | 89.36% | ↗ |
| 17 | 2022 | Arnon Rosenthal, Ph.D. Co-founder, Chief Executive Officer, and Director | 621.4K | — | 1.69M | 800.5K | 389.3K | 9.2K | 3.52M | 70.99% | ↗ |
| 18 | 2022 | Arnon Rosenthal, Ph.D. Co-founder, Chief Executive Officer | 621.4K | — | 1.69M | 800.5K | 389.3K | 9.2K | 3.52M | 70.99% | ↗ |
| 19 | 2022 | Robert King, Ph.D. Former Chief Development Officer | 385.3K | — | 204.1K | 96.4K | — | 6.9K | 692.7K | 43.38% | ↗ |
| 20 | 2022 | Linda Rubinstein | 116.4K | — | — | — | — | — | 116.4K | 0.00% | ↗ |
| 21 | 2021 | Arnon Rosenthal, Ph.D. Co-founder, Chief Executive Officer, and Director | 575.4K | — | 1.80M | 6.84M | 388.2K | 9.2K | 9.61M | 89.88% | ↗ |
| 22 | 2021 | Arnon Rosenthal, Ph.D. Co-founder, Chief Executive Officer | 575.4K | — | 1.80M | 6.84M | 388.2K | 9.2K | 9.61M | 89.88% | ↗ |
| 23 | 2021 | Shehnaaz Suliman , M.D. Former President and Chief Operating Officer | 500.0K | — | 1.20M | 816.3K | — | 773.2K | 3.29M | 61.31% | ↗ |
| 24 | 2021 | Robert King, Ph.D. Chief Development Officer | 437.5K | — | 681.3K | 584.0K | 214.0K | 7.3K | 1.92M | 65.76% | ↗ |
| 25 | 2021 | Robert King, Ph.D. Former Chief Development Officer | 437.5K | — | 681.3K | 584.0K | 214.0K | 7.3K | 1.92M | 65.76% | ↗ |
| 26 | 2021 | Calvin Yu Vice President, Finance | 308.3K | 90.0K | 470.7K | 385.2K | 114.6K | 6.8K | 1.38M | 62.22% | ↗ |
| 27 | 2021 | Robert Paul, M.D., Ph.D. Former Chief Medical Officer | 366.7K | — | 720.8K | — | — | 38.9K | 1.13M | 63.99% | ↗ |
| 28 | 2021 | Sara Kenkare-Mitra, Ph.D. President and Head of Research and Development | 25.9K | 500.0K | — | — | 26.8K | 28.00 | 526.8K | 0.00% | ↗ |
| 29 | 2021 | Linda Rubinstein | 306.2K | — | — | — | — | — | 306.2K | 0.00% | ↗ |
| 30 | 2021 | Linda Rubinstein Former Chief Financial Officer | 306.2K | — | — | — | — | — | 306.2K | 0.00% | ↗ |
| 31 | 2020 | Shehnaaz Suliman , M.D. Former President and Chief Operating Officer | 471.7K | — | — | 7.67M | 200.3K | 5.8K | 8.35M | 91.88% | ↗ |
| 32 | 2020 | Shehnaaz Suliman, M.D. President and Chief Operating Officer | 471.7K | — | — | 7.67M | 200.3K | 5.8K | 8.35M | 91.88% | ↗ |
| 33 | 2020 | Arnon Rosenthal, Ph.D. Co-founder, Chief Executive Officer, and Director | 554.2K | — | — | 3.10M | — | 11.9K | 3.66M | 84.54% | ↗ |
| 34 | 2020 | Robert King, Ph.D. Former Chief Development Officer | 414.6K | — | — | 836.0K | 134.3K | 7.3K | 1.39M | 60.05% | ↗ |
| 35 | 2020 | Robert King, Ph.D. Chief Development Officer | 414.6K | — | — | 836.0K | 134.3K | 7.3K | 1.39M | 60.05% | ↗ |
| 36 | 2020 | Robert Paul, M.D., Ph.D. Chief Medical Officer | 432.0K | — | — | 743.1K | 130.2K | 6.2K | 1.31M | 56.66% | ↗ |
| 37 | 2020 | Robert Paul, M.D., Ph.D. Former Chief Medical Officer | 432.0K | — | — | 743.1K | 130.2K | 6.2K | 1.31M | 56.66% | ↗ |
| 38 | 2020 | Calvin Yu Vice President, Finance | 295.0K | — | — | 457.5K | 71.1K | 4.8K | 828.3K | 55.23% | ↗ |
| 39 | 2019 | Arnon Rosenthal, Ph.D. Co-founder and Chief Executive Officer | 525.0K | — | — | 5.98M | 341.3K | 3.6K | 6.85M | 87.31% | ↗ |
| 40 | 2019 | Arnon Rosenthal, Ph.D. Co-founder, Chief Executive Officer, and Director | 525.0K | — | — | 5.98M | 341.3K | 3.6K | 6.85M | 87.31% | ↗ |
| 41 | 2019 | Robert Paul, M.D., Ph.D. Chief Medical Officer | 392.1K | — | — | 1.73M | 188.2K | 1.2K | 2.31M | 74.80% | ↗ |
| 42 | 2019 | Robert Paul, M.D., Ph.D. Former Chief Medical Officer | 392.1K | — | — | 1.73M | 188.2K | 1.2K | 2.31M | 74.80% | ↗ |
| 43 | 2019 | Robert King, Ph.D. Chief Development Officer | 362.5K | — | — | 1.73M | 166.8K | 2.3K | 2.26M | 76.46% | ↗ |
| 44 | 2018 | Arnon Rosenthal, Ph.D. Co-founder, Chief Executive Officer, and Director | 396.8K | — | — | 4.82M | 237.5K | 3.6K | 5.45M | 88.30% | ↗ |
| 45 | 2018 | Arnon Rosenthal, Ph.D. Co-Founder and Chief Executive Officer | 396.8K | 237.5K | — | 4.82M | — | 3.6K | 5.45M | 88.30% | ↗ |
| 46 | 2018 | Arnon Rosenthal, Ph.D. Co-founder and Chief Executive Officer | 396.8K | — | — | 4.82M | 237.5K | 3.6K | 5.45M | 88.30% | ↗ |
| 47 | 2018 | Robert Paul, M.D., Ph.D. Chief Medical Officer | 326.4K | 43.8K | — | 2.71M | 136.9K | 1.2K | 3.22M | 84.20% | ↗ |
| 48 | 2018 | Robert King, Ph.D. Chief Development Officer | 352.3K | — | — | 1.57M | 147.8K | 2.3K | 2.07M | 75.76% | ↗ |
| 49 | 2018 | Robert King, Ph.D. Chief Development Office r | 352.3K | 147.8K | — | 1.57M | — | 2.3K | 2.07M | 75.76% | ↗ |
| 50 | 2017 | Arnon Rosenthal, Ph.D. Co-Founder and Chief Executive Officer | 370.0K | 140.6K | 2.88M | — | — | 3.6K | 3.40M | 84.86% | ↗ |
| 51 | 2017 | Robert King, Ph.D. Chief Development Office r | 316.9K | 103.7K | 1.31M | — | — | 1.2K | 1.73M | 75.63% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Arnon Rosenthal | Co-Founder, Chief Executive Officer & Director | 1M | — |
| Giacomo Salvadore | Chief Medical Officer | 752.2K | male |
| Neil Berkley | CFO & Chief Business Officer | 705.1K | male |
| Danielle Pasqualone | General Counsel | — | female |
| Hua Long DABT | Senior VP & Head of Research | — | — |
| Katie Hogan | Senior Director of Corporate Communication & Investor Relations | — | female |
| Kristina Cutter | Chief Development Officer | — | female |
| Clare Hunt | Chief People & Places Officer | — | female |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ALEC
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
